Association between p21 Ser31Arg polymorphism and the development of cervical lesion in women infected with high risk HPV
Infection by high-risk human papillomavirus (HR-HPV) and single nucleotide polymorphism (SNP) in genes involved in cell cycle control, as p21 and p27, are important factors in the development of different types of human cancers. This study aims at investigating whether both the p21 Ser31Arg and p27 V109G polymorphisms are associated with susceptibility to the development of cervical lesions in women HR-HPV positive. We analyzed 132 women HPV positive and with cervical lesions or CC and 154 healthy control (HPV negative and without cervical lesions). p21 Ser31Arg and p27 V109G polymorphisms were analyzed using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method and sequencing. The p21 31Arg allele was associated with susceptibility for the development of cervical lesions (P* = 0.0009), while p27 V109G polymorphism showed no significant differences for this association (P* = 0.89). However, the combined effect of the polymorphisms showed that the presence of the CC genotype (SNP p21 Ser31Arg) conferred protection for the development of cervical lesions (OR = 0.39). p21 Ser31Arg and p27 V109G polymorphisms were not associated with the grade of cervical lesions (CINI, CINII, and CINIII) or CC (P* > 0.05). The HR-HPV more frequent in this study were of 16 (57.6 %) and 18 (37.1 %) types; however, no association was observed when both polymorphisms and risk factors analyzed were compared (P* > 0.05). Our findings suggest a possible association between p21 Ser31tabArg polymorphism and susceptibility to the development of cervical lesions in women from Pernambuco. Brazil.
KeywordsSNPs Cell cycle Cervical cancer HPV
Compliance with ethical standards
Conflict of interest
- 1.BRASIL. INCA. Instituto Nacional do Câncer. Ministério da Saúde. Cancer Prevalence Estimates 2014. Available online at: http://www.inca.gov.br/estimativa/2014/sintese-de-resultadocomentarios.asp (accessed May 13, 2014).
- 3.Insinga RP, Dasbach EJ, Elbasha EH. Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model. BMC Infect Dis. 2009;9:119.CrossRefPubMedPubMedCentralGoogle Scholar
- 6.Cotran RS, Kumar V, Collins T. Robbins: patologia estrutural e funcional. 6.ed. Rio de Janeiro: Guanabara Koogan. 2000Google Scholar
- 7.Kumar V, Abbas A, Fausto N, Mitchell RN. Robbins: patologia básica. 8.ed. Rio de Janeiro: Guanabara Koogan. (2010)Google Scholar
- 9.Eleutério Junior J, Giraldo PC, Gonçalves AK. Marcadores imunoistoquímicos de lesões precursoras do câncer de colo uterino associadas ao HPV: o papel da proteína de supressão tumoral p16ink4a. DST J Bras Doenças Sex Transm. 2006;18(1):62–5.Google Scholar
- 10.Knebel MD. p16INK4a as a biomarker for differentiating replicating and transforming high risk HPV infections: the theoretical concept and its potential diagnostic impact HPV today, Newsletter on Human Papillomavirus. 2009; 7–8, M– 35437–2001.Google Scholar
- 26.Tae KY, Kyoung CE, Hoon CN, Hung KJ, Ick Yang W, Wook KJ, et al. Expression of cyclin E and p27KIP1 in cervical carcinoma. Cancer Lett. 2000;153(1–2):41–50.Google Scholar
- 29.Solomon MR, Bamossy GJ, Askegaard S. Consumer behaviour: European perspective. London: Pearson Education Limited; 2002.Google Scholar
- 30.Associacão Brasileira de Genitoscopia. Nomenclatura para laudos Colposcópico. 2002; Available online at: http://www.colposcopy.org.br (accessed august 2015).
- 32.Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells. 1989;7:209–14.Google Scholar
- 44.Oliveira-Silva M, Lordello CX, Zardo LM, Bonvicino CR, Moreira MA. Human papillomavirus in Brazilian women with and without cervical lesions. 2011; Virol J 8:4.Google Scholar